Frank­furt am Main — A team from the law firm HEUKING has advi­sed Harald Quandt Indus­trie­be­tei­li­gun­gen GmbH (HQIB) on the acqui­si­tion of Insti­tut Virion Serion GmbH and its Chinese joint venture (Virion\Serion). Virion\Serion has been active in the deve­lo­p­ment, manu­fac­ture and distri­bu­tion of in-vitro diagno­stics (IVD) for the diagno­sis of viral, bacte­rial, fungal and para­si­tic dise­a­ses for over 45 years. As a global supplier, the company offers both raw mate­ri­als and diagno­stic products. These are used by over 400 custo­mers, mainly labo­ra­to­ries and rese­arch insti­tu­tes, in more than 100 countries.

HQIB acqui­red Virion\Serion with the aim of further deve­lo­ping the medium-sized company in the long term. The main focus is on the further expan­sion of the raw mate­ri­als area and further inter­na­tio­na­liza­tion. With the help of HQIB’s finan­cial resour­ces and exper­tise, stra­te­gic acqui­si­ti­ons of comple­men­tary tech­no­lo­gies and product groups should further acce­le­rate growth. The manage­ment team around CEO Dr. Judith Stür­mer will remain with Virion\Serion beyond the transaction.

About HQIB

As an invest­ment holding company, HQIB invests in small and medium-sized compa­nies in German-spea­king count­ries that are active in estab­lished, future-orien­­ted and tech­ni­cally sophisti­ca­ted sectors with attrac­tive growth poten­tial. The focus is on the areas of secu­rity, digi­ta­liza­tion and health. HQIB holds invest­ments in a total of 23 compa­nies. As an indus­trial holding company, HQIB pursues a long-term and sustainable invest­ment approach and is not subject to any matu­rity rest­ric­tions or limi­ted holding periods.

Advi­sor Harald Quandt Indus­trie­be­tei­li­gun­gen GmbH: HEUKING

Dr. Pär Johans­son, photo (© Heuking), lead part­ner (corpo­rate law / M&A),
Markus Schmül­l­ing (labor law),
Dr. Verena Hoene, LL.M. (IP, Media & Technology),
Kris­tina Schnei­der, LL.M. (corpo­rate law / M&A), all Cologne,
Dr. Henrik Lay (tax law), Hamburg,
Dr. Katha­rina Pras­uhn (Corpo­rate Law / M&A), Munich,
Dr. Chris­toph Schork, LL.M. (Corpo­rate Law / M&A), Cologne